


OptoSeeker
Also known as Optoseeker Biotechnology (Shenzhen)
Builds lab instruments that move and screen single cells with light (optoelectronic tweezers), for antibody discovery, cell-line development and cell and gene therapy. It pitches the time-stamped single-cell function data they produce as training data for AI biology models.
Money and evidence
No research by this company is on the record yet.
Rounds and research, on one timeline
- 2026-10-08Pre-ARound
over CNY 50M
For: develop and engineer its core products, validate them in key applications, and explore an AI-driven technical service built on single-cell function data
Wet labData generation
Announced on the company's own news page; PEdaily carried it a day later with the same quotes. No valuation. The company says it has raised three rounds since 2023: Lingyi Ventures joined all three, InnoAngel Fund the first and led the second, Nanshan's funds the last two. The second round's date and size are not given.
Lead · Shenzhen Capital GroupGuangdong Traditional Chinese Medicine and Health FundNanshan SEI InvestmentExisting investor · Lingyi Ventures
On the deal: Lianfa Zheng (Founding Partner; spoke for the firm in the announcement, Lingyi Ventures); Muyang He (Investment Director; spoke for the firm in the announcement, Shenzhen Capital Group); Xiao Yang (Assistant General Manager; spoke for the fund in the announcement, Guangdong Traditional Chinese Medicine and Health Fund)
Announced by the company · optoseeker.com ↗On the timeline →
- 2023-11AngelRound
tens of millions of yuan
Not stated
The company's history page gives the month and size; the two investors are from its October 2026 announcement, which says both took part in its first round.
Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.
Its investors also backed
Other companies on this page whose rounds name the same investor.
- Shenzhen Capital GroupMoleculeMind
- InnoAngel FundFieldQuantum